Hans Wijkström

Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program

Torgrim Tandstad, Olav Dahl, Gabriella Cohn‐Cedermark et al. · Journal of Clinical Oncology · 2009 · 266 citations · Full text

Medicine, Oncology, Cancer Control +15

5-YEAR FOLLOWUP OF A RANDOMIZED PROSPECTIVE STUDY COMPARING MITOMYCIN C AND BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER CARCINOMA

Per‐Uno Malmström, Hans Wijkström, CARL LUNDHOLM et al. · The Journal of Urology · 1999 · 254 citations

Medicine, Oncology, Urology +14

Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer.

Lennart Hardell, Bert van Bavel, Gunilla Lindström et al. · Environmental Health Perspectives · 2002 · 216 citations · Full text

Pharmacy, Oncology, Toxicology +14

Distressful symptoms after radical radiotherapy for urinary bladder cancer

Lars Henningsohn, Hans Wijkström, Paul W. Dickman et al. · Radiotherapy and Oncology · 2002 · 141 citations

Medicine, Oncology, Urology +9

Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.

Petra Berggren, Rajiv Kumar, Shigeru Sakano et al. · PubMed · 2003 · 104 citations

Medicine, Molecular Genetics, Oncology +17